These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27992105)

  • 1. Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?
    Devi P; Rutledge PJ
    Chembiochem; 2017 Feb; 18(4):338-351. PubMed ID: 27992105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases.
    Johnson JW; Gretes M; Goodfellow VJ; Marrone L; Heynen ML; Strynadka NC; Dmitrienko GI
    J Am Chem Soc; 2010 Mar; 132(8):2558-60. PubMed ID: 20141132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclobutanone Mimics of Intermediates in Metallo-β-Lactamase Catalysis.
    Abboud MI; Kosmopoulou M; Krismanich AP; Johnson JW; Hinchliffe P; Brem J; Claridge TDW; Spencer J; Schofield CJ; Dmitrienko GI
    Chemistry; 2018 Apr; 24(22):5734-5737. PubMed ID: 29250863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.
    Tomoshige S; Dik DA; Akabane-Nakata M; Madukoma CS; Fisher JF; Shrout JD; Mobashery S
    ACS Infect Dis; 2018 Jun; 4(6):860-867. PubMed ID: 29716193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and studies of new forms of N-sulfonyloxy β-lactams as potential antibacterial agents and β-lactamase inhibitors.
    Carosso S; Miller MJ
    Bioorg Med Chem; 2015 Sep; 23(18):6138-47. PubMed ID: 26321604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
    Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
    Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Lactamases: A Focus on Current Challenges.
    Bonomo RA
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
    Buynak JD
    Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic strategies and medicinal properties of beta-lactams.
    Kidwai M; Sapra P; Bhushan KR
    Curr Med Chem; 1999 Mar; 6(3):195-215. PubMed ID: 10219100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase Inhibitors.
    Nguyen TV; Blackledge MS; Lindsey EA; Minrovic BM; Ackart DF; Jeon AB; Obregón-Henao A; Melander RJ; Basaraba RJ; Melander C
    Angew Chem Int Ed Engl; 2017 Mar; 56(14):3940-3944. PubMed ID: 28247991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams.
    King DT; Sobhanifar S; Strynadka NC
    Protein Sci; 2016 Apr; 25(4):787-803. PubMed ID: 26813250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DD-carboxypeptidase-transpeptidase and killing site of beta-lactam antibiotics in Streptomyces strains R39, R61, and K11.
    Dusart J; Marquet A; Ghuysen JM; Frère JM; Moreno R; Leyh-Bouille M; Johnson K; Lucchi C; Perkins HR; Nieto M
    Antimicrob Agents Chemother; 1973 Feb; 3(2):181-7. PubMed ID: 4790585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming resistance to β-lactam antibiotics.
    Worthington RJ; Melander C
    J Org Chem; 2013 May; 78(9):4207-13. PubMed ID: 23530949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Actions and resistance mechanisms of beta-lactam antibiotics. Penicillin-binding proteins, beta-3-lactamases and signal proteins].
    Heisig P
    Pharm Unserer Zeit; 2006; 35(5):400-8. PubMed ID: 17009783
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin".
    Silvaggi NR; Josephine HR; Kuzin AP; Nagarajan R; Pratt RF; Kelly JA
    J Mol Biol; 2005 Jan; 345(3):521-33. PubMed ID: 15581896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-lactam analogues of beta-lactam antibiotics.
    Baldwin JE; Lynch GP; Pitlik J
    J Antibiot (Tokyo); 1991 Jan; 44(1):1-24. PubMed ID: 2001979
    [No Abstract]   [Full Text] [Related]  

  • 20. In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-β-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria.
    Decuyper L; Deketelaere S; Vanparys L; Jukič M; Sosič I; Sauvage E; Amoroso AM; Verlaine O; Joris B; Gobec S; D'hooghe M
    Chemistry; 2018 Oct; 24(57):15254-15266. PubMed ID: 29882610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.